SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-16-004649
Filing Date
2016-03-10
Accepted
2016-03-10 07:02:45
Documents
14
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 20-F zk1618165.htm 20-F 3637394
2 EXHIBIT 4.18 exhibit_4-18.htm EX-4.18 176681
3 EXHIBIT 4.40 exhibit_4-40.htm EX-4.40 288739
4 EXHIBIT 4.41 exhibit_4-41.htm EX-4.41 589145
5 EXHIBIT 12.1 exhibit_12-1.htm EX-12.1 16238
6 EXHIBIT 12.2 exhibit_12-2.htm EX-12.2 16440
7 EXHIBIT 13.1 exhibit_13-1.htm EX-13.1 5399
8 EXHIBIT 13.2 exhibit_13-2.htm EX-13.2 5327
9 EXHIBIT 15.5 exhibit_15-5.htm EX-15.5 4710
10 pwc.jpg GRAPHIC 3415
11 bioline.jpg GRAPHIC 5830
12 bioline2.jpg GRAPHIC 5131
13 logo.jpg GRAPHIC 9061
14 img.jpg GRAPHIC 89495
  Complete submission text file 0001178913-16-004649.txt   4897282
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-35223 | Film No.: 161496128
SIC: 2834 Pharmaceutical Preparations